Hims & Hers stock rises as CEO clarifies tweet supporting anti-Israel protestors

Shares of Hims & Hers Health (NYSE:HIMS) rebounded premarket Monday following a sharp drop on Friday amid controversial tweets from CEO Andrew Dudum.

HIMS rose 6% before the bell, following an 8% decline on Friday.

On May 1, before market trading, Dudum posted on X, formerly Twitter, "If you’re currently protesting against the genocide of the Palestinian people & for your university’s divestment from Israel, keep going. It’s working. There are plenty of companies & CEOs eager to hire you, regardless of university discipline."

He also added a link to the Hims & Hers careers page.

Shares closed only fractionally down on May 1 and down 2% on May 2, but sank 8% on Friday on volume 3x average.

On Sunday, Dudum tweeted out a thread that he said was to clarify his words that had been misconstrued.

He said: "I, in no way condone nor support acts or threats of violence, antisemitism, or intimidation and there is absolutely no justification for violence on our campuses. Every student deserves to feel safe without fear of harm or being targeted for who they are. I am deeply saddened that my support for peaceful protest has been interpreted by some as encouraging violence, intimidation, or bigotry of any kind."

"I do believe deeply in the right for people to use their voices in peaceful protest to drive change. This right is critical to our democracy and must be protected. Our world today is more just because students throughout history have courageously taken to their campuses and used their voices to force change. Generations of Americans have engaged in non-violent protest, and these movements have led to some of the most important changes in our country’s history."

The telehealth company will report earnings after the bell today.

Dear readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion.